Interferon- : A Therapeutic for Autoimmune Lupus in MRL-Faslpr Mice

Journal of the American Society of Nephrology : JASN - United States
doi 10.1681/asn.2004111014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

Deficient Leptin Signaling Ameliorates Systemic Lupus Erythematosus Lesions in MRL/Mp-Faslpr Mice

Journal of Immunology
AllergyImmunology
2014English

IL-34–Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-Faslpr Mice

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2019English

Deoxyspergualin Therapy in Autoimmune MRL/1pr Mice Suffering Advanced Lupus-Like Disease.

Journal of Antibiotics
Drug DiscoveryPharmacology
1990English

Negative Role of Colony-Stimulating Factor-1 in Macrophage, T Cell, and B Cell Mediated Autoimmune Disease in MRL-Faslpr Mice

Journal of Immunology
AllergyImmunology
2004English

ALW Peptide Ameliorates Lupus Nephritis in MRL/lpr Mice

Arthritis Research & Therapy
2019English

Reduced Receptor Editing in Lupus-Prone MRL/lpr Mice

Journal of Experimental Medicine
MedicineAllergyImmunology
2007English

Reduction of Lupus Nephritis in MRL/lpr Mice by a Bacterial Superantigen Treatment

Journal of Experimental Medicine
MedicineAllergyImmunology
1991English

The New Complement Inhibitor CRIg/FH Ameliorates Lupus Nephritis in Lupus-Prone MRL/lpr Mice

BMC Nephrology
Nephrology
2019English

Toll-Like Receptor 9 Suppresses Lupus Disease in Fas-Sufficient MRL Mice

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy